Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018;48(3):168-171.
doi: 10.1159/000491881. Epub 2018 Sep 3.

The Successful Use of Apixaban in Dialysis Patients With Calciphylaxis Who Require Anticoagulation: A Retrospective Analysis

Affiliations

The Successful Use of Apixaban in Dialysis Patients With Calciphylaxis Who Require Anticoagulation: A Retrospective Analysis

Anna C Garza-Mayers et al. Am J Nephrol. .

Abstract

Calciphylaxis is a disease of dermal arteriolar calcification that results in necrosis. It commonly occurs in individuals with end-stage renal disease (ESRD) on hemodialysis and is associated with a high morbidity and mortality. Warfarin use is an identified risk factor. Twenty patients with ESRD on dialysis with calciphylaxis who were treated with apixaban for indications of deep vein thrombosis or atrial fibrillation were identified. There were no reports of thrombosis. Three individuals experienced bleeding requiring a transfusion, and anticoagulation was resumed without further event. Findings suggest that apixaban may be a safe and effective alternative to warfarin in patients with ESRD on dialysis with calciphylaxis.

Keywords: Apixaban; Calcific uremic arteriolopathy; Calciphylaxis; Dialysis; Warfarin.

Comment in

Similar articles

See all similar articles

Cited by 6 articles

See all "Cited by" articles

Publication types

MeSH terms

Feedback